Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma
The Journal of Clinical Endocrinology & Metabolism · 2023
DOI: 10.1210/clinem/dgad173 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2023. Verfasst von Nicholas Kesby und 12 weiteren Autor:innen. Beteiligte Einrichtung: Endocrine Surgery Unit, Royal North Shore Hospital, Northern Sydney Local Health District, St Leonards, NSW 2065, Australia. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Carcinoma, Medullary, Peptide Hormones, Bone Density Conservation Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cancer Institute NSW Early Career Fellowship.
Abstract (Originalsprache)
Context
Management of sporadic medullary thyroid microcarcinoma smaller than 1 cm (micro-MTC) is controversial because of conflicting reports of prognosis. As these cancers are often diagnosed incidentally, they pose a management challenge when deciding on further treatment and follow-up.
Objective
We report the outcomes of surgically managed sporadic micro-MTC in a specialist endocrine surgery and endocrinology unit and identify associations for recurrence and disease-specific survival in this population.
Methods
Micro-MTCs were identified from a prospectively maintained surgery database, and slides were reviewed to determine pathological grade. The primary end points were recurrence, time to recurrence and disease-specific survival. Prognostic factors assessed included size, grade, lymph node metastasis (LNM), and postoperative calcitonin.
Results
From 1995 to 2022, 64 patients were diagnosed with micro-MTC with 22 excluded because of hereditary disease. The included patients had a median age of 60 years, tumor size of 4 mm, and 28 (67%) were female. The diagnosis was incidental in 36 (86%) with 4 (10%) being high grade, 5 (12%) having LNM and 9 (21%) having elevated postoperative calcitonin. Over a 6.6-year median follow-up, 5 (12%) developed recurrence and 3 (7%) died of MTC. High grade and LNM were associated with 10-year survival estimates of 75% vs 100% for low grade and no LNM (hazard ratio = 831; P < .01). High grade, LNM, and increased calcitonin were associated with recurrence (P < .01). Tumor size and type of surgery were not statistically significantly associated with recurrence or survival. No patients with low grade micro-MTC and normal postoperative calcitonin developed recurrence.
Conclusion
Most sporadic micro-MTCs are detected incidentally and are generally associated with good outcomes. Size is not significantly associated with outcomes. Using grade, LNM, and postoperative calcitonin allows for the identification of patients at risk of recurrence to personalize management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrine Surgery Unit, Royal North Shore Hospital, Northern Sydney Local Health District, St Leonards, NSW 2065, Australia.
- The Kinghorn Cancer Centre, Garvan Institute of Medical Research, St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Darlinghurst, NSW 2010, Australia.
- Clarunis, University Hospital Basel, Basel, Basel-Stadt 4031, Switzerland.
- NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.
- Northern Clinical School, Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2065, Australia.
- Department of Endocrinology, Royal North Shore Hospital, Northern Sydney Local Health District, St Leonards, NSW 2065, Australia.
ORCID-Profile: Nicholas Kesby, Anthony Glover
Förderung
- Cancer Institute NSW Early Career Fellowship
Zitieren
APA
Kesby, N., Mechera, R., Fuchs, T., Papachristos, A., Gild, M., Tsang, V., Clifton-Bligh, R., Robinson, B., Sywak, M., Sidhu, S., Chou, A., Gill, A. J., & Glover, A. (2023). Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad173
Vancouver
Kesby N, Mechera R, Fuchs T, Papachristos A, Gild M, Tsang V, et al. Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma. The Journal of Clinical Endocrinology & Metabolism. 2023. doi:10.1210/clinem/dgad173
BibTeX
@article{Kesby2023,
author = {Kesby, Nicholas and Mechera, Robert and Fuchs, Talia and Papachristos, Alexander and Gild, Matti and Tsang, Venessa and Clifton-Bligh, Roderick and Robinson, Bruce and Sywak, Mark and Sidhu, Stan and Chou, Angela and Gill, Anthony J and Glover, Anthony},
title = {Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2023},
doi = {10.1210/clinem/dgad173}
}
EUVIMED